Capital Fund Management (CFM)
WVE icon

Capital Fund Management (CFM)’s Wave Life Sciences WVE Stock Holding History

Capital Fund Management (CFM)’s Portfolio WVE Stock Details WVE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$4.27M Buy
734,746
+551,415
+301% +$3.66M 0.02% 1008
2026
Q1 		$1.33M Buy
+183,331
New +$2.39M 0.01% 1556

Other funds holding WVE

RCM
RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
GP
GSK plc London $602M AUM
MC
Maverick Capital Dallas, Texas $11.3B AUM 76.6% 1-Year Est. Return
DCM
Driehaus Capital Management Chicago, Illinois $17.3B AUM 211.34% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
6CM
683 Capital Management New York $2.04B AUM 94.26% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
RAM
Readystate Asset Management Chicago, Illinois $2.93B AUM 18.57% 1-Year Est. Return

Capital Fund Management (CFM)'s WVE Position: Q2 2026 in Review

Capital Fund Management (CFM) increased its Wave Life Sciences (WVE) stake by 301% in Q2 2026, buying an estimated $3.66M and bringing the position to 734,746 shares worth $4.27M. The position accounts for 0.02% of the portfolio, ranked #1008.

Capital Fund Management (CFM) first reported a position in WVE in Q1 2026 and has held it in 2 quarters since. 239 funds tracked by Wall St. Rank hold WVE as of Q2 2026.

  • Capital Fund Management (CFM) held 734,746 shares of Wave Life Sciences worth $4.27M as of Q2 2026.
  • Capital Fund Management (CFM) bought 551,415 Wave Life Sciences shares in Q2 2026, an estimated $3.66M.
  • Wave Life Sciences made up 0.02% of Capital Fund Management (CFM)'s portfolio in Q2 2026, its #1008 holding.
  • Capital Fund Management (CFM) first reported a position in Wave Life Sciences in Q1 2026 and has held it in 2 quarters since.
  • 239 funds tracked by Wall St. Rank held Wave Life Sciences as of Q2 2026.

Based on Capital Fund Management (CFM)'s 13F filing for Q2 2026, filed 13 Aug 2026.